OVERVIEW
Cancer immunotherapy has brought major improvements to patient survival and quality of life when compared with previous standards of care, whether it be surgery, radiotherapy or chemotherapy. It is now a pillar of cancer care, having moved earlier in patient management from the metastatic setting to as early as the neoadjuvant setting in numerous cancer types. The understanding of how immune cells recognise and kill cancer cells, and how we can enhance their ability to fight cancer, is now essential for anyone working to develop new cancer treatments or apply them in clinic.
During this unique online conference, the esteemed experts from Dana-Farber Cancer Institute/Gustave Roussy/Paris-Saclay University will review their latest clinical research and data covering a broad spectrum of immuno-oncology. We are pleased to announce that the keynote will be given by Professor William Kaelin, the 2019 Nobel Prize in Physiology or Medicine recipient.
Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology!
8:30 EST / 14:30 CEST
Chairmen Introduction
Fabrice Barlesi, MD, PhD/Toni Choueiri, MD
8:45 EST / 14:45 CEST
Keynote: The VHL Tumor Suppressor Gene as a Rosetta Stone for Kidney Cancer
William G Kaelin, Jr., MD
9:25 EST / 15:25 CEST
cGAS-Like Receptors Reveal New Signals Controlling Innate Immunity
Philip Kranzusch, PhD
9:55 EST / 15:55 CEST
Epigenetic Control of T Cell Memory and CAR T cell Persistence
Sebastian Amigorena, PhD
10:30 EST / 16:30 CEST MORNING BREAK
11:00 EST / 17:00 CEST
Immunogenic Cell Stress and Death
Guido Kroemer, MD, PhD
11:30 EST / 17:30 CEST
Tumour Macrophage Heterogeneity
Florent Ginhoux, PhD
12:00 EST / 18:00 CEST LUNCH BREAK
13:00 EST / 19:00 CEST
Microbiota-Centered Interventions for the Future of Immuno-Oncology
Laurence Zitvogel, MD, PhD
13:30 EST / 19:30 CEST
Engineered NK Cells for Enhanced Cancer Immunotherapy
Rizwan Romee, MD
14:00 EST / 20:00 CEST
GPRC5D- and Dual-Targeted CAR T Cell Therapy
Eric Smith, MD, PhD
14:30 EST / 20:30 CEST
Translation Control in Melanoma
Caroline Robert, MD, PhD
15:00 EST / 21:00 CEST AFTERNOON BREAK
15:30 EST / 21:30 CEST
On the Path to Better Cancer Vaccines
Catherine J. Wu, MD
16:00 EST / 22:00 CEST
Immune Contexture and Immunoscore in the Era of Cancer Immunotherapy
Jérôme Galon, PhD
16:30 EST / 22:30 CEST
The Biology Behind PD-1 Checkpoint Blockade
Arlene Sharpe, MD, PhD
17:00 EST / 23:00 CEST
Conference Conclusion
Guido Kroemer, MD, PhD / Kai Wucherpfennig, MD, PhD
ADJOURN